136 related articles for article (PubMed ID: 35901496)
1. Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.
Punt A; Bos P; Hakkert B; Louisse J
ALTEX; 2023; 40(2):237–247. PubMed ID: 35901496
[TBL] [Abstract][Full Text] [Related]
2. Predictive Performance of Next Generation Physiologically Based Kinetic (PBK) Model Predictions in Rats Based on In Vitro and In Silico Input Data.
Punt A; Louisse J; Pinckaers N; Fabian E; van Ravenzwaay B
Toxicol Sci; 2022 Feb; 186(1):18-28. PubMed ID: 34927682
[TBL] [Abstract][Full Text] [Related]
3. Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data.
Punt A; Louisse J; Beekmann K; Pinckaers N; Fabian E; Van Ravenzwaay B; Carmichael PL; Sorrell I; Moxon TE
ALTEX; 2022; 39(2):221–234. PubMed ID: 35064272
[TBL] [Abstract][Full Text] [Related]
4. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
5. PBK modelling of topical application and characterisation of the uncertainty of C
Li H; Reynolds J; Sorrell I; Sheffield D; Pendlington R; Cubberley R; Nicol B
Toxicol Appl Pharmacol; 2022 May; 442():115992. PubMed ID: 35346730
[TBL] [Abstract][Full Text] [Related]
6. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
[TBL] [Abstract][Full Text] [Related]
7. Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical Application.
Najjar A; Schepky A; Krueger CT; Dent M; Cable S; Li H; Grégoire S; Roussel L; Noel-Voisin A; Hewitt NJ; Cardamone E
Front Pharmacol; 2021; 12():802514. PubMed ID: 35058784
[TBL] [Abstract][Full Text] [Related]
8. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome
Zhao S; Wesseling S; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 May; 96(5):1387-1409. PubMed ID: 35294598
[TBL] [Abstract][Full Text] [Related]
9. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine.
Ning J; Rietjens IMCM; Strikwold M
Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935
[TBL] [Abstract][Full Text] [Related]
10. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
11. Bottom-up physiologically-based biokinetic modelling as an alternative to animal testing.
Chan JCY; Tan SPF; Upton Z; Chan ECY
ALTEX; 2019; 36(4):597-612. PubMed ID: 31079160
[TBL] [Abstract][Full Text] [Related]
12. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
[TBL] [Abstract][Full Text] [Related]
13. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
14. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
Poulin P; Bteich M; Haddad S
J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
[TBL] [Abstract][Full Text] [Related]
15. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
16. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
[TBL] [Abstract][Full Text] [Related]
17. Predicting human tissue exposures to xenobiotics using a bottom-up physiologically-based biokinetic model.
Tan SPF; Chan ECY; Chan JCY
ALTEX; 2021; 38(2):253-268. PubMed ID: 33219385
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
[TBL] [Abstract][Full Text] [Related]
19. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
